HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

undecyl 2-(4-chlorophenoxy)propionate

Also Known As:

ufibrate

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Carboxylic Acids: 973
  - Acyclic Acids
    - Propionates: 988
      - undecyl 2-(4-chlorophenoxy)propionate: 1
Lipids: 114793
- Fatty Acids: 27405
  - Volatile Fatty Acids: 3052
    - Propionates: 988
      - undecyl 2-(4-chlorophenoxy)propionate: 1

Related Diseases

1.	Hyperlipidemias (Hyperlipidemia) 09/01/1997 - "Ufibrate (150 mg daily) was found to have a beneficial effect on main parameters characterizing lipid metabolism, with no effect being exerted on carbohydrate metabolism, as evidenced by three months' follow-up of 24 patients aged 42 to 65 presenting with insulin-nondependent type II diabetes mellitus and hyperlipidemia. "
2.	Type 2 Diabetes Mellitus (MODY) 09/01/1997 - "[The antidyslipoproteinemic activity of ufibrate in patients with non-insulin-dependent diabetes mellitus]."
3.	Diabetes Mellitus 09/01/1997 - "Ufibrate (150 mg daily) was found to have a beneficial effect on main parameters characterizing lipid metabolism, with no effect being exerted on carbohydrate metabolism, as evidenced by three months' follow-up of 24 patients aged 42 to 65 presenting with insulin-nondependent type II diabetes mellitus and hyperlipidemia. "

Related Drugs and Biologics

1.	Insulin (Novolin)